Antibodies in neurological diseases: Established, emerging, explorative
LY Li, A Keles, MA Homeyer, H Prüss - Immunological reviews, 2024 - Wiley Online Library
Within a few years, autoantibodies targeting the nervous system resulted in a novel disease
classification. For several of them, which we termed 'established', direct pathogenicity has …
classification. For several of them, which we termed 'established', direct pathogenicity has …
MAD—microbial (origin of) Alzheimer's disease hypothesis: from infection and the antimicrobial response to disruption of key copper-based systems
JH Min, H Sarlus, RA Harris - Frontiers in Neuroscience, 2024 - frontiersin.org
Microbes have been suspected to cause Alzheimer's disease since at least 1908, but this
has generally remained unpopular in comparison to the amyloid hypothesis and the …
has generally remained unpopular in comparison to the amyloid hypothesis and the …
[HTML][HTML] Infectious Disease as a Modifiable Risk Factor for Dementia: A Narrative Review
This narrative review examines infectious diseases as modifiable risk factors for dementia,
particularly in the context of an aging global population. As the prevalence of Alzheimer's …
particularly in the context of an aging global population. As the prevalence of Alzheimer's …
Current status of immunisation for herpes zoster
AL Cunningham, KJ Sandgren… - Human Vaccines & …, 2025 - Taylor & Francis
Herpes zoster (HZ) is increasingly common in the aging and is experienced by
approximately one in three people in their lifetime. It is also relatively common in immune …
approximately one in three people in their lifetime. It is also relatively common in immune …
[HTML][HTML] The effect of herpes zoster vaccination at different stages of the disease course of dementia: Two quasi-randomized studies
The varicella zoster virus, a neurotropic herpesvirus, has been hypothesized to play a role in
the pathophysiology of dementia, such as through neuroinflammatory processes or …
the pathophysiology of dementia, such as through neuroinflammatory processes or …
Recombinant zoster vaccine and the risk of dementia
Background Herpes zoster is a potential risk factor for dementia. The effectiveness of the
recombinant zoster vaccine for preventing dementia is uncertain. Methods This retrospective …
recombinant zoster vaccine for preventing dementia is uncertain. Methods This retrospective …
Enhancing longevity: the additional benefits of vaccination in older adults
M Woodward - Microbiology Australia, 2024 - CSIRO Publishing
Vaccination of older people (over age 60) reduces the impact of some preventable microbial
diseases but has additional benefits including reducing cancer, reducing dementia and …
diseases but has additional benefits including reducing cancer, reducing dementia and …
A couple of words about the shingles vaccine: a novelty in the Polish doctor's office
Z Cudziło, H Sawczuk, WE Nowak… - Forum …, 2025 - journals.viamedica.pl
Herpes zoster is caused by the reactivation of a primary infection of the varicella-zoster virus.
It is particularly common among older individuals, with estimates suggesting that one in …
It is particularly common among older individuals, with estimates suggesting that one in …
[HTML][HTML] Become a Premium Member
P Attia - peterattiamd.com
Does pharmacological treatment for ADHD increase risk of cardiovascular disease? Skip to
content Peter Attia Newsletter Weekly Newsletter The free weekly newsletter explores practical …
content Peter Attia Newsletter Weekly Newsletter The free weekly newsletter explores practical …
[HTML][HTML] Shingles vaccine can reduce risk of dementia in California seniors
M Simpson - local.newsbreak.com
A new study published in a peer-reviewed journal concludes that the shingles vaccine can
significantly reduce the risk of dementia in California seniors. This supports a previous study …
significantly reduce the risk of dementia in California seniors. This supports a previous study …